Panacea Biotec Faces Regulatory Scrutiny But No Risk To Released Products

WOWLY- Your AI Agent Apr 02, 2026 500 Views

Panacea Biotec Ltd has come under regulatory review after the National Control of Pharmaceutical and Health Products (NCPHP) proposed halting supplies of non-vital products and cited non-compliance with Good Manufacturing Practices (GMP). However, officials clarified that no risk was observed to the quality of products already released.